Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2003
10/02/2003US20030186906 Mixture comprising an inhibitor or suppresor of a gene and a molecule binding to an expression product of that gene
10/02/2003US20030186905 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone3' -untranslated region
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186881 Nucleotide sequences comprising complementary DNA codes for cyclin-dependent kinases, that control phosphorylation in cells, used in diagnosis and prophylaxis of diseases
10/02/2003US20030186875 Uses of mammalian cytokine; related reagents
10/02/2003US20030186422 Methods for the treatment of thrombosis
10/02/2003US20030186421 Comprises lipoprotein associated phospholipase A2 (Lp-PLA2) for diagnosing and treating atherosclerosis; enzyme inhibitors
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186408 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186407 Comprises membrane protein for use as antitumor/antiproliferative/antiinflammatory/anticarcinogenic agents
10/02/2003US20030186391 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purpose
10/02/2003US20030186385 Method of identifying polypeptide monobodies which bind to target proteins and use thereof
10/02/2003US20030186384 Comprises enzyme complex formed from proteases for modulating apoptosis and treating tumor, allergenic, autoimmune diseases and inflammatory diseases
10/02/2003US20030186383 Comprise nucleotide sequences coding growth factor polypeptide for diagnosing and treating autoimmune, cell proliferative, atherosclerotic, inflammatory and cancer disorders; tissue engineering; wound healing agents
10/02/2003US20030186381 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/02/2003US20030186375 Comprises actin binding protein for use in prevention and treatment of cell proliferative disorders; gene expression inhibition
10/02/2003US20030186369 Egg specific surface proteins
10/02/2003US20030186367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186366 For stimulating release of tumor necrosis factor and/or cellular differentiation of chondrocytes, endothelial cells or adipocytes by contacting blood with pro-polypeptide; cancer diagnosis and treatment
10/02/2003US20030186359 Genes encoding insect odorant receptors and uses thereof
10/02/2003US20030186358 Comprise nucleotide sequences coding membrane protein for use as antitumor, antiproliferative, anticarcinogenic or antiinflammatory agents
10/02/2003US20030186356 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
10/02/2003US20030186343 Immunoglobulin which binds low density lipoprotein receptor for diagnosis, prevention or treatment of viral infections; viricides
10/02/2003US20030186342 Immunoenzymatic quantification method
10/02/2003US20030186340 Amino acid sequences for use as diagnostic markers in bioassays; immunohistochemistry
10/02/2003US20030186338 Marker for diagnosing breast cancers and ovarian cancers
10/02/2003US20030186335 Monoclonal antibody for use as diagnostic tool in the isolation of cells from the ependymal and subependymal layers of human brain
10/02/2003US20030186333 Comprises nervous system polypeptide for diagnosis, prognosis, treatment and evaluation of neurodegenerative disorders
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186321 Comprises polypeptide having antitumor, immunomodulatory and viricidal activity for treating leukemia, hepatitis and autoimmune diseases
10/02/2003US20030186319 Comprises nucleotide sequences coding membrane protein for use as antiinflammatory/antitumor/anticarcinogenic/ antiproliferative agents
10/02/2003US20030186318 Comprises nucleotide sequences coding membrane protein for use as antiinflammatory/antitumor/anticarcinogenic/ antiproliferative agents
10/02/2003US20030186317 Identifying modulators of calcium-binding protein (CIB)/mixed lineage kinase 2 (MLK2) complexes for treatment and prevention of nervous system disorders
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030186305 Novel proteins
10/02/2003US20030186290 Gene involved in CADASIL, method of diagnosis and therapeutic application
10/02/2003US20030186275 Using bacterial peptides to develop vaccine to protect against mycobacterium infections
10/02/2003US20030186269 Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
10/02/2003US20030186264 Comprises enzymatic polypeptide for diagnosis and treatment of genetic disorders; drug screening; immunoassay; high throughput assay
10/02/2003US20030186253 Fibroblast growth factor-13
10/02/2003US20030186232 Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereof
10/02/2003US20030186225 Comprises DNA sequences coding viral protein for use in developing vaccine which prevents porcine reproductive and respiratory syndrome viral infections
10/02/2003US20030185856 Immunizing young hens with antigen proteins of E. coli
10/02/2003US20030185852 Parasitic protozoan isolate
10/02/2003US20030185849 React with convalescent phase antiserum from an E. canis-infected dog; useful in the development of vaccines and serodiagnostics
10/02/2003US20030185845 Such as variants of interleukin 5 and tumour necrosis factor alpha
10/02/2003US20030185842 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185833 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
10/02/2003US20030185832 Administering a targeting agent operatively attached to a therapeutic agent; the targeting agent recognizes and binds to a tumor-associated endothelial cell marker.
10/02/2003US20030185830 Compositions and methods for the therapy and diagnosis of prostate cancer
10/02/2003US20030185827 Stimulating remyelination of central nervous system axons by administering a monoclonal antibody characterized by their ability to bind structures and cells within the central nervous system, including oligodendrocytes.
10/02/2003US20030185826 Administering as a TNF antagonist for reducing neuronal tissue inflammation a fusion protein identified as etanercept, infliximab, CDP571, CDP 870, D2E7, soluble TNF receptor Type I, or pegylated soluble TNF receptor Type I
10/02/2003US20030185825 Novel immunotoxins and methods of inducing immune tolerance
10/02/2003US20030185824 Administering an inhibitor of the CD2/LFA-3 interaction, in combination with an auxiliary agent, such as UV-B
10/02/2003US20030185823 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
10/02/2003US20030185821 Antibodies to interleukin-4 receptors and uses thereof
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185818 Humanized antibody against cd18
10/02/2003US20030185817 Method for separating cells using immunorosettes
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185800 Human interferon-epsilon: a type I interferon
10/02/2003US20030185796 Methods of therapy for non-hodgkin's lymphoma
10/02/2003CA2480561A1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes
10/02/2003CA2480559A1 Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells
10/02/2003CA2480099A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003CA2480059A1 Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13r.alpha.1)
10/02/2003CA2480050A1 Tenascin-w compositions and uses thereof
10/02/2003CA2480034A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003CA2479896A1 A mutated immunoglobulin-binding protein
10/02/2003CA2479732A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003CA2479731A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003CA2479730A1 Novel compositions and methods in cancer
10/02/2003CA2479727A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003CA2479723A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003CA2479721A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003CA2479719A1 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003CA2479576A1 Antibody that binds to a dimer of a prion protein for the treatment of tse infection
10/02/2003CA2479306A1 Egfr ligands and methods of use
10/02/2003CA2478839A1 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003CA2478063A1 Lymphatic and blood endothelial cell genes
10/02/2003CA2475529A1 Methods for treating chronic obstructive pulmonary disease (copd)
10/01/2003EP1348768A2 Method of treatment, diagnosis or detection of diabetes
10/01/2003EP1348715A2 CD19xCD3 specific polypeptides and uses thereof
10/01/2003EP1348128A2 Method of diagnosing a transmissible spongiform encephalopathy
10/01/2003EP1348036A2 Protection against mycobacterial infections
10/01/2003EP1348027A2 Gene disruption methodologies for drug target discovery
10/01/2003EP1348022A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/01/2003EP1347994A2 Canine and feline tumour-associated antigen 5t4
10/01/2003EP1347993A2 Superficial zone protein and methods of making and using same
10/01/2003EP1347992A2 Polymorphic bone morphogenetic protein 2
10/01/2003EP1347774A2 Modulation of cell growth by inhibiting binding of kringle 2 domain of plasminogen
10/01/2003EP1347770A2 Method of making a protein polymer and uses of the polymer
10/01/2003EP1347730A2 Recombinant anti-cd30 antibodies and uses thereof
10/01/2003EP1100830B1 Heterominibodies
10/01/2003EP0937105B1 DNA encoding the variable region of an anti-idiotypic antibody
10/01/2003EP0912612B1 Simplified production of bispecific antibody fragments
10/01/2003EP0638172B1 Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446228A 校正基因 Correction gene
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
1 ... 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 ... 1494